DB
LGND icon

Danske Bank’s Ligand Pharmaceuticals LGND Stock Holding History

Danske Bank’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-100
Closed -$18.9K – 1393
2025
Q4 		$18.9K Hold
100
– – ﹤0.01% 1205
2025
Q3 		$17.7K Sell
100
-51
-34% -$7.58K ﹤0.01% 1182
2025
Q2 		$17.2K Sell
151
-13,779
-99% -$1.47M ﹤0.01% 1209
2025
Q1 		$1.46M Buy
13,930
+887
+7% +$100K ﹤0.01% 758
2024
Q4 		$1.4M Buy
13,043
+4,297
+49% +$486K ﹤0.01% 800
2024
Q3 		$875K Buy
+8,746
New +$880K ﹤0.01% 834

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

Danske Bank's LGND Position: Q1 2026 in Review

Danske Bank sold out of Ligand Pharmaceuticals (LGND) in Q1 2026, closing a stake of 100 shares — an estimated $18.9K sold.

Danske Bank first reported a position in LGND in Q3 2024 and held it in 6 quarters. The position peaked at $1.46M in Q1 2025. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.

  • Danske Bank reported no remaining Ligand Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Danske Bank sold 100 Ligand Pharmaceuticals shares in Q1 2026, an estimated $18.9K.
  • Danske Bank first reported a position in Ligand Pharmaceuticals in Q3 2024 and held it in 6 quarters.
  • Danske Bank's Ligand Pharmaceuticals position peaked at $1.46M in Q1 2025.
  • 357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.

Based on Danske Bank's 13F filing for Q1 2026, filed 12 May 2026.